GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the income earned by banks from the fund they have on their balance sheet. Synageva BioPharma Corp's net interest income for the three months ended in Jun. 2014 was $0.10 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2014 was $0.34 Mil.
Synageva BioPharma Corp's quarterly net interest income declined from Dec. 2013 ($0.10 Mil) to Mar. 2014 ($0.08 Mil) but then increased from Mar. 2014 ($0.08 Mil) to Jun. 2014 ($0.10 Mil).
Synageva BioPharma Corp's annual net interest income increased from Dec. 2011 ($-0.03 Mil) to Dec. 2012 ($0.07 Mil) and increased from Dec. 2012 ($0.07 Mil) to Dec. 2013 ($0.34 Mil).
Income earned by banks from the fund they have on their balance sheet. These funds can be from customers' deposit, bank's own equity or borrowed.
Synageva BioPharma Corp Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2014 was 0.073 (Sep. 2013 ) + 0.097 (Dec. 2013 ) + 0.075 (Mar. 2014 ) + 0.098 (Jun. 2014 ) = $0.34 Mil.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data